OKUR

OnKure Therapeutics

• Reuters·3d ago

  OnKure Therapeutics initial beneficial ownership filing names AI Biotechnology LLC as 10% owner

• TipRanks·4d ago

  OnKure Therapeutics (OKUR) Gets a Buy from JonesTrading

• Reuters·04/01 21:24

  OnKure Therapeutics files Form 3; director Liam Ratcliffe reports no beneficial ownership

• Reuters·03/30 11:16

  ONKURE THERAPEUTICS INC <OKUR.O>: LEERINK PARTNERS CUTS TARGET PRICE TO $11 FROM $29

• TipRanks·03/30 10:41

  OnKure Announces $150M Private Placement and Board Changes

• Reuters·03/30 10:09

  OnKure Therapeutics prices private placement at about $150 million gross proceeds

• Reuters·03/30 07:35

  U.S. RESEARCH ROUNDUP- Ferguson Enterprises, Hartford Insurance Group, JP Morgan

• Seeking Alpha·03/27 12:32

  OnKure Therapeutics prices $150M oversubscribed private placement

• NASDAQ·03/27 12:28

  Pre-Market Most Active for Mar 27, 2026 : TQQQ, TSLL, IBIT, OKUR, ETHA, SQQQ, LAR, U, SNAP, NOK, NIO, IONQ

• TipRanks·03/27 12:22

  OnKure Therapeutics to sell 26.713M shares at $4.15 in private placement

• Benzinga·03/27 12:12

  OnKure Therapeutics Enters Into Securities Purchase Agreement For Private Placement Raising Gross Proceeds Of ~$150M

• Benzinga·03/27 12:05

  12 Health Care Stocks Moving In Friday's Pre-Market Session

• Dow Jones·03/27 12:02

  *OnKure Therapeutics: Expect to File INDs for Each Program in 1H 2027 >OKUR

• Dow Jones·03/27 12:02

  *OnKure Therapeutics: Liam Ratcliffe Joins Bd of Directors >OKUR

• Reuters·03/27 12:00

  ONKURE THERAPEUTICS ANNOUNCES OVERSUBSCRIBED $150 MILLION PRIVATE PLACEMENT TO ADVANCE NEXT-GENERATION PI3KΑ PAN-MUTANT SELECTIVE INHIBITOR CANDIDATES IN BREAST CANCER AND VASCULAR ANOMALIES